sacituzumab
gilead sciences
['tropics02', 'bcsm']
 presents #tropics02 os for #hr+ #bcsm with at least 2 prior chemo: median of 3 prior chemos prior reported pfs 4.0 vs. 5.5 mo os by 3.2 months (11.2 to 14.4 months) orr : 14 to 21% time to deterioration endpoints improved #esmo22 
Med Onc, Director of Breast & GYN Research Program @ Sarah Cannon Research Institute #bcsm #gyncsm #WomenInMedicine USAF Wife, Mom to 2 girls, tweets are mine.